Publications by authors named "F A ARNOLD"

HIV-associated neurocognitive disorders (HAND) and viral reservoirs in the brain remain a significant challenge. Despite their importance, the mechanisms allowing HIV-1 entry and replication in the central nervous system (CNS) are poorly understood. Here, we show that α-synuclein and (to a lesser extent) Aβ fibrils associated with neurological diseases enhance HIV-1 entry and replication in human T cells, macrophages, and microglia.

View Article and Find Full Text PDF

Directed evolution (DE) is a powerful tool to optimize protein fitness for a specific application. However, DE can be inefficient when mutations exhibit non-additive, or epistatic, behavior. Here, we present Active Learning-assisted Directed Evolution (ALDE), an iterative machine learning-assisted DE workflow that leverages uncertainty quantification to explore the search space of proteins more efficiently than current DE methods.

View Article and Find Full Text PDF

Tandem repeat (TR) size variation is implicated in ~50 neurological disorders, yet its impact on gene regulation in the human brain remains largely unknown. In the present study, we quantified the impact of TR size variation on brain gene regulation across distinct molecular phenotypes, based on 4,412 multi-omics samples from 1,597 donors, including 1,586 newly sequenced ones. We identified ~2.

View Article and Find Full Text PDF

Sequence-function data provides valuable information about the protein functional landscape but is rarely obtained during directed evolution campaigns. Here, we present Long-read every variant Sequencing (LevSeq), a pipeline that combines a dual barcoding strategy with nanopore sequencing to rapidly generate sequence-function data for entire protein-coding genes. LevSeq integrates into existing protein engineering workflows and comes with open-source software for data analysis and visualization.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to explore the long-term impacts of COVID-19 on key vascular structures and clinical outcomes in individuals who had the virus.
  • Conducted at a post-COVID-19 clinic, the trial involved 72 post-COVID patients and 11 control participants, with follow-up assessments at 3, 6, and 12 months post-diagnosis.
  • Results indicated increased median intima-media thickness (IMT) in COVID-19 patients compared to controls, changes in blood cell markers and responses based on severity of infection, but no instances of deep vein thrombosis were found.
View Article and Find Full Text PDF